Utilization of lipoxins and other specialised pro-resolving mediators in the prevention and treatment of diabetic nephropathy and diabetic cardiovascular disease
Diabetes mellitus type 2 is a chronic disease caused by insulin resistance. Whilst first originating in the adipose tissue, this pathophysiological process later affects the muscles and the liver as well. This induces high plasma levels of glucose and fatty acids, leading to the inflammatory-related...
Saved in:
| Main Authors: | Bergo Ivan, Pastorello Ylenia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2024-12-01
|
| Series: | Acta Marisiensis - Seria Medica |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/amma-2024-0037 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction
by: Ting Fu, et al.
Published: (2024-11-01) -
Actinidia deliciosa as a complemental therapy against nephropathy and oxidative stress in diabetic rats
by: Ali Y. Naoom, et al.
Published: (2023-11-01) -
The state of lipid metabolism in patients with diabetic nephropathy
by: Lola Daminova, MD, PhD, DSc, et al.
Published: (2024-12-01) -
Exploring Inflammatory Changes in the Peripheral Blood of Type 2 Diabetes Mellitus in China
by: Li D, et al.
Published: (2025-02-01) -
Serum Ferritin Levels in Pregnancy and Their Association with Gestational Diabetes Mellitus: A Prospective Longitudinal Study
by: Qin Z, et al.
Published: (2025-02-01)